Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Annexon (ANNX) Shares Outstanding (Diluted Average) (2021 - 2026)

Annexon's Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $194.2 million for Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) rose 31.12% to $194.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $194.2 million through Mar 2026, up 31.12% year-over-year, with the annual reading at $155.1 million for FY2025, 12.88% up from the prior year.
  • Shares Outstanding (Diluted Average) came in at $194.2 million for Q1 2026, up from $155.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $194.2 million in Q1 2026 to a low of $38.6 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $122.7 million (2024), against an average of $105.7 million.
  • Year-over-year, Shares Outstanding (Diluted Average) increased 0.77% in 2022 and then soared 95.03% in 2023.
  • Annexon's Shares Outstanding (Diluted Average) stood at $54.7 million in 2022, then skyrocketed by 38.41% to $75.7 million in 2023, then soared by 81.58% to $137.4 million in 2024, then grew by 12.88% to $155.1 million in 2025, then increased by 25.2% to $194.2 million in 2026.
  • Per Business Quant, the three most recent readings for ANNX's Shares Outstanding (Diluted Average) are $194.2 million (Q1 2026), $155.1 million (Q4 2025), and $149.1 million (Q3 2025).